Metis Global Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.54M | Sell |
32,437
-14,081
| -30% | -$1.1M | 0.07% | 264 |
|
|
2025
Q1 | $3.37M | Buy |
46,518
+2,407
| +5% | +$174K | 0.09% | 189 |
|
|
2024
Q4 | $3.27M | Buy |
44,111
+2,902
| +7% | +$215K | 0.1% | 174 |
|
|
2024
Q3 | $2.72M | Buy |
41,209
+3,340
| +9% | +$220K | 0.08% | 211 |
|
|
2024
Q2 | $3.5M | Buy |
37,869
+306
| +0.8% | +$28.3K | 0.12% | 141 |
|
|
2024
Q1 | $3.59M | Sell |
37,563
-107
| -0.3% | -$10.2K | 0.13% | 129 |
|
|
2023
Q4 | $2.87M | Buy |
37,670
+3,024
| +9% | +$231K | 0.11% | 159 |
|
|
2023
Q3 | $2.4M | Buy |
34,646
+4,231
| +14% | +$293K | 0.12% | 175 |
|
|
2023
Q2 | $2.87M | Buy |
30,415
+842
| +3% | +$79.4K | 0.15% | 132 |
|
|
2023
Q1 | $2.45M | Buy |
29,573
+6,249
| +27% | +$517K | 0.16% | 131 |
|
|
2022
Q4 | $1.74M | Buy |
23,324
+10,243
| +78% | +$764K | 0.16% | 140 |
|
|
2022
Q3 | $1.08M | Buy |
13,081
+1,682
| +15% | +$139K | 0.17% | 134 |
|
|
2022
Q2 | $1.08M | Buy |
11,399
+1,533
| +16% | +$146K | 0.17% | 134 |
|
|
2022
Q1 | $1.16M | Buy |
9,866
+4,431
| +82% | +$522K | 0.14% | 136 |
|
|
2021
Q4 | $704K | Buy |
+5,435
| New | +$704K | 0.2% | 122 |
|